Key facts
- Superstring Capital Management is a hedge fund based in New York, New York with 3 tracked portfolio companies.
- Notable positions include Caidya, ReCode Therapeutics, Trinomab(Zhuhai).
- Superstring Capital Management reports $181.0M in regulatory assets under management across 2 private funds, per its SEC Form ADV (2026-03).
About Superstring Capital Management
249920-20P
Registered with the SEC
Form ADV · 2026-03 · CRD 305743- Regulatory AUM
- $181.0M
- Private fund assets
- $315.7M
- Private funds
- 2 · 1 private equity, 1 hedge
- Staff
- 5
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as SUPERSTRING CAPITAL MANAGEMENT LP).
Free account
See the whole book
- ·Watchlist + alerts for Superstring Capital Management's activity
Create free account
No card required
Portfolio, priced
3 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Caidya | Other Healthcare Services | $1.0B | — | |
| ReCode Therapeutics | — | $700.0M | — | |
| Trinomab(Zhuhai) | — | $533.7M | — |
Frequently asked
- What companies does Superstring Capital Management invest in?
- Superstring Capital Management has 3 recorded portfolio companies, including Caidya, ReCode Therapeutics, Trinomab(Zhuhai).
- What is Superstring Capital Management's AUM?
- Superstring Capital Management manages approximately $181.0M in assets.